|Outsourcing OutlookEric LangerYear in Review: Trends in Biopharma Manufacturing Outsourcing|
|Regulatory WatchJill WechslerFDA Realigns Drug Inspection and Manufacturing Oversight|
|Ask The ExpertSiegfried Schmitt Good Distribution Practices: Who is Responsible?|
The fast growth of the global biopharmaceutical market has prompted global pharmaceutical and biotechnology companies to increase their R&D investment in biologics.
Novasep has entered into an agreement with Celladon to provide scale-up and pre-validation studies for the drug substance for MYDICAR.
SGS Life Science Services adds analytical methods to identify amino acid impurities in bio/pharmaceutical manufacturing at facility in Germany.